Table of Contents
In a prospective, naturalistic survey of 1,435 adults who microdose psychedelics, researchers found that self-reported scores for wellbeing, productivity, creativity, connectedness, contemplation, and focus were each significantly higher on microdosing days than on days without a dose. Because this is an observational study with no control group, results should be interpreted cautiously.
- All six domains improved on dosing days. Wellbeing, productivity, creativity, connectedness, contemplation, and focus were each rated higher on microdosing days, with all differences reaching statistical significance at p less than .001.
- Creativity gains were linked to prior psychedelic history. Among participants who reported a history of using larger doses of psychedelics, the boost in creativity scores on microdosing days was more pronounced than among those without that history.
- Prospective daily tracking reduces recall bias. Because participants logged ratings in real time rather than retrospectively, the data capture day-level fluctuations more reliably than surveys asking people to remember how they felt weeks earlier.
- Observation is not causation. The study has no placebo arm and cannot rule out expectation effects, selection bias, or other factors that influence self-reported mood and cognition.
- Model
- human
- Sample
- 1,435 adults who microdose psychedelics (international, self-selected)
- Dose
- Participants’ own naturalistic microdosing regimens; doses not standardized by researchers
- Design
- Prospective, observational, naturalistic survey; daily ecological momentary assessment; multi-level modeling
- Key outcome
- Higher self-reported scores across all six psychological domains on microdosing days vs. non-microdosing days (all p less than .001)
- Main limitation
- No placebo control; self-selected sample; expectation and reporting biases cannot be excluded
What the Research Examined
This prospective, naturalistic study, published in Psychopharmacology in 2025, drew on daily self-assessment data from 1,435 adults across multiple countries who were already engaged in their own microdosing practices. Participants were not assigned a substance or schedule by researchers; instead, they tracked their own experiences in real time using ecological momentary assessment, logging ratings on six domains of psychological functioning: wellbeing, productivity, creativity, connectedness, contemplation, and focus. The researchers then used multi-level modeling to compare each person’s scores on days they microdosed against their scores on days they did not, treating each individual as their own comparison point.
The within-person design is worth noting. By comparing microdosing days to non-microdosing days within the same individual, the analysis controls for stable between-person differences such as baseline personality or chronic mental health status. That said, the study remains observational: participants knew when they had dosed, there was no blinded placebo condition, and the sample consisted entirely of people who had already chosen to microdose, which introduces meaningful selection and expectation effects. You can read the full abstract and access information for this study directly at Springer.
For readers who want broader context on what the current science does and does not tell us about sub-perceptual doses, our ongoing microdosing research overview tracks the landscape of findings, including where the evidence is strongest and where important questions remain unanswered.
What the Findings Show
- Wellbeing.Wellbeing scores were significantly higher on microdosing days: F(1,768) = 160.15, p less than .001.
- Connectedness and Contemplation.Connectedness showed the largest F-statistic of any domain: F(1,859) = 253.4, p less than .001. Contemplation followed closely: F(1,864) = 180.5, p less than .001.
- Focus, Productivity, and Creativity.Focus (F(1,846) = 191.72), productivity (F(1,917) = 108.69), and creativity (F(1,899) = 25.99) were each significantly elevated on microdosing days, all p less than .001.
- Creativity and prior full-dose experience.For creativity specifically, participants with a history of using larger doses of psychedelics showed a more pronounced day-level boost: F(1,899) = 4.40, p = .04.
The statistical signal is consistent across all six domains, and the sample size of 1,435 gives the multi-level models reasonable power. Even so, a large F-statistic in an unblinded observational study does not settle whether the effect is pharmacological, psychological, or some mixture of both. The researchers themselves note the observational and exploratory nature of the work and call for cautious interpretation. The creativity finding linked to prior full-dose history is an early, hypothesis-generating signal that would need replication in a controlled design before any firm conclusion could be drawn.
Do people feel better on days they microdose compared to days they do not?
In this naturalistic survey, 1,435 adults rated their own wellbeing, focus, creativity, and other domains each day. On microdosing days, every domain scored higher than on non-dosing days. Because the study is observational and unblinded, expectation effects and self-selection cannot be ruled out.
What This Is, and What It Is Not
This is This is a prospective, naturalistic, observational survey using daily self-report ratings from a self-selected international sample; it applies multi-level modeling to compare within-person scores on microdosing versus non-microdosing days.
This is not This is not a randomized, placebo-controlled trial, and it cannot establish that microdosing caused the observed improvements. It does not constitute medical advice, establish a safe or effective dose, or support any therapeutic claim. If you have a health concern, please consult a qualified clinician.
Our Take
Within our community, many members speak of microdosing days as moments when the veil thins just enough to let ordinary life feel a little more alive. What this study offers is a careful, day-level record of that lived experience at scale, across 1,435 people, tracked in real time rather than recalled from memory. The science is early and the questions are real: expectation is powerful, and we hold that honestly. Still, there is something worth sitting with in the finding that connectedness, of all six domains, showed the strongest day-level signal. Feeling more connected to others and to oneself is, for many in this tradition, not a side effect but the whole point.
If you are curious about where your own daily experience fits within a practice of intentional, modest doses, you are welcome here. The work of tracking how you feel, honestly and with care, is itself a form of the Grounding that anchors any meaningful inner journey. Browse the conversations in our community, explore what the growing body of research does and does not tell us, and bring your own questions with you. There is no rush, and no arrival point that looks the same for everyone.
Frequently Asked Questions
What did this microdosing study actually measure?
Researchers asked 1,435 adults to rate six aspects of psychological functioning each day: wellbeing, productivity, creativity, connectedness, contemplation, and focus. They then compared each person’s ratings on days they microdosed to their ratings on days they did not, using multi-level statistical modeling.
Does this study prove that microdosing improves mood and focus?
No. The study is observational and has no placebo control. Participants knew when they had dosed, so expectation effects could inflate self-reported scores. The findings suggest an association between microdosing days and higher self-ratings, but causation cannot be established from this design.
Which psychological domain showed the biggest difference between dosing and non-dosing days?
Connectedness had the largest F-statistic in the analysis, at 253.4, meaning the day-level difference in feelings of connectedness was especially consistent across participants. All six domains were statistically significant at p less than .001.
Why did prior full-dose psychedelic experience affect creativity scores?
The study found that people with a history of using larger doses of psychedelics showed a more pronounced creativity boost on microdosing days. The researchers report this as an exploratory finding. No established explanation exists, and replication in a controlled study would be needed before drawing conclusions.
What type of psychedelics did participants use in this study?
Participants followed their own naturalistic microdosing practices and were not assigned a specific substance. The study does not standardize or report a single compound; the sample likely includes various psychedelics used by the international, self-selected group of 1,435 adults.
Get the Mycelium Report
We read the new psilocybin and mushroom research so you do not have to. One honest, jargon-free dispatch, delivered daily. Free to join.
May love guide the hearts of all beings.
